IGFBP7 and acute kidney injury: Recent studies assessing urinary biomarkers for predicting AKI induced by HDMTX have shown that elevated levels of the combination of tissue inhibitor of metalloproteinases-2 and insulin-like growth factor-binding protein 7 (TIMP2∗IGFBP7) is associated with an increased risk of HDMTX-related AKI.